Recent Updates
Recently added Catalysts
FULC Positive Sentiment

Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

Thursday, May 29, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Fulcrum Therapeutics, a clinical-stage biopharmaceutical company, announced its participation in the 46th Annual Goldman Sachs Global Healthcare Conference. The event will take place on June 11, 2025, at 8:00 am ET in Miami, FL, and will feature a fireside chat with management. Interested parties can access the webcast online, with a replay available for at least 30 days thereafter. This participation highlights Fulcrum's focus on developing treatments for genetically defined rare diseases.
Price reaction · baseline $6.9 (2025-05-28 close) · hit after-hours · clean, no other FULC news in the window
day 0 close
+2.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Fulcrum Therapeutics is showcasing its commitment to rare disease treatment.
  • Participation in a prominent healthcare conference can enhance visibility.
  • Management's engagement indicates confidence in their pipeline and strategy.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
15.6%
average across 6 past catalysts
Cash runway
~59 mo
Minimal dilution risk
Lead asset
Pociredir
Phase 2 · Sickle Cell Disease

Full Press Release Details

CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in a fireside chat at the 46th Annual Goldman Sachs Global Healthcare Conference in Miami, FL on Wednesday, June 11, 2025 at 8:00 am ET.
The webcast of the fireside chat will be accessible HERE or by visiting the "Events and Presentations" section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations. A replay of the webcast will be available on Fulcrum Therapeutics’ website for at least 30 days following the presentation.
About Fulcrum Therapeutics

Frequently Asked Questions

When is Fulcrum Therapeutics participating in the conference?

Fulcrum Therapeutics will participate on June 11, 2025, at 8:00 am ET.

Where can I watch the Fulcrum Therapeutics webcast?

The webcast can be accessed on their website under the 'Events and Presentations' section.

How long will the webcast replay be available?

The replay of the webcast will be available for at least 30 days post-presentation.

What is the focus of Fulcrum Therapeutics?

Fulcrum Therapeutics develops small molecules for genetically defined rare diseases.

ShareAdd on Google
Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics Goldman Sachs Conference rare diseases biopharmaceutical company healthcare conference
Last updated: May 29, 2025

Biotech snapshot

Cash runway
$319M liquidity · $5M/mo burn
~59 mo
Minimal dilution risk
Lead asset
PociredirPhase 2
Sickle Cell Disease →

Catalyst track record

+32%
best trade around FULC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for FULC.

See every catalyst's timing & PoA →